Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Return on Capital Employed (2016 - 2025)

Marimed (MRMD) has disclosed Return on Capital Employed for 14 consecutive years, with 0.0% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Capital Employed fell 4.0% to 0.0% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.0%, a 4.0% decrease, with the full-year FY2024 number at 0.02%, down 8.0% from a year prior.
  • Return on Capital Employed was 0.0% for Q3 2025 at Marimed, up from 0.0% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.39% in Q2 2021 to a low of 0.0% in Q1 2025.
  • A 5-year average of 0.15% and a median of 0.11% in 2023 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: skyrocketed 173bps in 2021, then decreased -22bps in 2022.
  • Marimed's Return on Capital Employed stood at 0.29% in 2021, then plummeted by -42bps to 0.17% in 2022, then tumbled by -47bps to 0.09% in 2023, then crashed by -79bps to 0.02% in 2024, then plummeted by -82bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Return on Capital Employed are 0.0% (Q3 2025), 0.0% (Q2 2025), and 0.0% (Q1 2025).